The roles of CCL2 in the aetiology of obesity and diabetes, the regulatory mechanisms, and the effect of therapies that inhibit CCL2 production have been recently reviewed [4, 41]. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.